PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-23.47%
Both yoy net incomes decline, with CRK at -99.56%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
6.36%
D&A growth well above CRK's 2.64%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-318.94%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
97.02%
Slight usage while CRK is negative at -503.90%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
637.40%
Well above CRK's 217.90%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
98.00%
Some CFO growth while CRK is negative at -41.17%. John Neff would note a short-term liquidity lead over the competitor.
9.45%
Some CapEx rise while CRK is negative at -23.44%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
94.44%
Growth of 94.44% while CRK is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
25.42%
We have mild expansions while CRK is negative at -23.44%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
85.03%
Debt repayment growth of 85.03% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
746.59%
Stock issuance far above CRK's 115.33%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-26.20%
We cut yoy buybacks while CRK is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.